Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
CEDOC, Chronic Diseases Research Centre, NOVA Medical School, Lisbon, Portugal.
Acta Neurol Scand. 2022 Nov;146(5):545-552. doi: 10.1111/ane.13677. Epub 2022 Aug 16.
Non-REM sleep symptoms remain poorly understood in alpha-synucleinopathies.
The aims of the study were to compare sleep stability and transitions, arousals, and sleep cycle structure between isolated rapid eye movement (REM) sleep behavior disorder (iRBD), Parkinson's disease (PD), and dementia with Lewy Bodies (DLB).
Sleep transition and stability measures were assessed in one-night video-polysomnography records. Transition measures were the number of shifts between Wake and REM, Wake and NREM, and REM and NREM. Stability measures were the number of passages within the same sleep stage. We assessed arousals, the number/duration of sleep cycles (defined as a sequence of any NREM stage to REM), and the duration of N3 and REM sleep in each cycle. These variables were compared between two sets of groups (PD vs. DLB vs. iRBD and RDB+ vs. RBD-).
We assessed 54 PD, 24 DLB, and 21 iRBD patients (54 RBD+, 22 RBD-). There were no significant differences regarding sleep stability measures. Arousal indices in N1 and N2 stages were significantly higher in PD compared with iRBD. 24% of the sample did not have any sleep cycle. PD had significantly fewer cycles than iRBD. Differences became non-significant when adjusting for medication. There was no effect of group or time of night in REM or N3 duration. There were no significant differences between RBD+ and RBD-.
There were no significant differences in stability/transition measures. Arousals and disturbance in sleep cycling were higher in PD, but the difference was no longer significant after adjusting for medication.
Different alpha-synucleinopathies have a similar degree of non-REM sleep instability, but medication could worsen symptoms in PD.
非快速眼动(NREM)睡眠症状在α-突触核蛋白病中仍未得到很好的理解。
本研究旨在比较孤立性快速眼动睡眠行为障碍(iRBD)、帕金森病(PD)和路易体痴呆(DLB)患者之间的睡眠稳定性和转换、觉醒以及睡眠周期结构。
在一夜视频多导睡眠图记录中评估睡眠转换和稳定性测量。转换测量指标包括从觉醒到 REM、从觉醒到 NREM 以及从 REM 到 NREM 的转换次数。稳定性测量指标为同一睡眠阶段内的转换次数。我们评估了觉醒次数、睡眠周期数/持续时间(定义为任何 NREM 阶段到 REM 的序列)以及每个周期中的 N3 和 REM 睡眠时间。这些变量在两组(PD 与 DLB 与 iRBD 和 RBD+与 RBD-)之间进行了比较。
我们评估了 54 例 PD、24 例 DLB 和 21 例 iRBD 患者(54 例 RBD+、22 例 RBD-)。在睡眠稳定性测量方面,没有显著差异。与 iRBD 相比,PD 患者在 N1 和 N2 阶段的觉醒指数显著更高。24%的样本没有任何睡眠周期。PD 的睡眠周期明显少于 iRBD。调整药物后,差异不再显著。REM 或 N3 持续时间不受组或夜间时间的影响。RBD+与 RBD-之间没有显著差异。
在稳定性/转换测量方面没有显著差异。PD 患者的觉醒和睡眠循环紊乱程度更高,但调整药物后,差异不再显著。
不同的α-突触核蛋白病患者的 NREM 睡眠不稳定性程度相似,但药物可能会使 PD 患者的症状恶化。